| |
| |
|
| Insider
Information: |
Kouchakji Elias |
| Relationship: |
SVP, Clinical Dev, Dru... |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
147,346 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$167,974 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
147,346 |
|
|
| Total
Value |
$167,974 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Fibrogen Inc |
FGEN |
SVP, Clinical Dev, Dru... |
2021-03-08 |
147,346 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2021-03-08 |
4 |
D |
$33.37 |
$174,225 |
D/D |
(5,221) |
147,346 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2021-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
20,800 |
152,567 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2020-12-07 |
4 |
D |
$41.99 |
$114,549 |
D/D |
(2,728) |
131,767 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2020-11-17 |
4 |
OE |
$14.58 |
$103,220 |
D/D |
7,082 |
134,495 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2020-09-08 |
4 |
D |
$42.16 |
$115,012 |
D/D |
(2,728) |
127,413 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2020-06-08 |
4 |
D |
$33.61 |
$91,688 |
D/D |
(2,728) |
130,141 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2020-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
132,191 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2020-03-06 |
4 |
D |
$39.71 |
$259,108 |
D/D |
(6,525) |
94,691 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2019-12-06 |
4 |
D |
$47.39 |
$115,726 |
D/D |
(2,442) |
101,216 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2019-09-06 |
4 |
D |
$41.68 |
$230,949 |
D/D |
(5,541) |
103,658 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2019-06-28 |
4 |
AS |
$45.00 |
$129,285 |
D/D |
(2,873) |
109,199 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2019-06-18 |
4 |
OE |
$14.58 |
$233,200 |
D/D |
16,000 |
112,072 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2019-06-06 |
4 |
D |
$38.31 |
$78,842 |
D/D |
(2,058) |
96,072 |
0 |
- |
|
| FGEN |
Fibrogen Inc |
SVP, Clinical Dev, Drug Safety |
• – – |
2019-05-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
97,512 |
|
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
